ABPI
House of Lords unloads both barrels on Government’s life science strategy approach
April 26, 2018Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical
The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …
Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
UK High Court rejects ABPI’s challenge to new NICE cost curbs
October 5, 2017Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical
The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …
The October 2017 issue of Pharmafocus is now live!
September 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, Pharmafocus
The October edition of Pharmafocus is now live! You can read it here.
Brexit Health Alliance warns that UK/EU negotiations put patients at risk
August 1, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BioIndustry Association, Brexit Health Alliance, NHS, brexit, drugs, healthcare, life sciences, pharma, pharmaceuticals
Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …
UK underperforming in cancer care compared to Europe, according to ABPI report
July 18, 2017Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical
According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …
ABPI launches legal action to overturn £20m price cap
July 11, 2017Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE
When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
ABPI reveals 10% increase in HCP payment disclosure
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, disclosure, disclosure uk
The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for …
Astellas receives further year suspension from ABPI
June 26, 2017Medical Communications, Sales and Marketing ABPI, Astellas
The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …
ABPI appoints new Executive Director of Government Affairs
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI
The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
What the life sciences industry wants from the next UK government
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences
The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
Could robots solve the pharma talent crisis?
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis
Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
ABPI calls for a “world-class NHS” with 2017 General Election Manifesto
April 27, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election
With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …
Changing levels of investment in UK drug discovery
March 31, 2017Medical Communications, Research and Development ABPI, drug discovery, report
Key drug discovery investment trends
Latest content
FibroFind appoints Lee Borthwick as CEO
